Presence of primitive lymphoid progenitors with NK or B potential in ex vivo expanded bone marrow cell cultures

Objective. In previous work, we showed that CD34(+) bone marrow cells can be successfully expanded along the myeloid pathway in stroma- and serum-free conditions in the presence of SCF+IL-3+IL-6+Flt3-1+G-CSF+MGDF. Due to the lack of phenotypically detectable lymphoid cells, it was necessary to address the question of the lymphoid potential of the expanded populations under these conditions. Materials and Methods. The present report describes a Long-term culture system that supports human B- and NK-cell differentiation from the day 14 fraction without further selection of the more primitive cells. In NK proliferation assays, the cells were maintained over stroma cells in the presence of IL-2 for 4-5 weeks. NK initiating cells (NK-IC) were determined by a limiting dilution assay, In B-cell cultures, the expanded cells were maintained over MS5 in the presence of Flt3-1 for 4-8 weeks. Results. NK cells rose from 0.2% +/- 0.04% at culture initiation to 71% +/- 6% at week 5. These cells displayed cytolytic activity, NK-IC evaluation showed a mean 18-fold expansion in the day 14 expanded fraction as compared to the initial day 0 fraction, Similarly, CD19(+) cells rose from 0.1% at culture initiation to 30% +/- 1% at week 6. Cells produced under these B-LTC conditions were CD34(-)CD19(+)CD10(+). We also demonstrated that the CD34(+)/Lin(-) sorted cells from the day 14 fraction gave rise to NK and B cells. Conclusion. This culture system permits the revelation of a population that, although poorly represented in terms of phenotypically detectable cells, nevertheless retains high levels of lymphoid NK and B potential after 14 days expansion. Such data suggest the persistence, or expansion, of lymphoid progenitors and, hence, the multipotentiality of the expanded progenitor/stem cells, (C) 2000 International Society for Experimental Hematology. Published by Elsevier Science Inc.